Tina Aswani-Omprakash, MPH
@ownyourcrohns.bsky.social
570 followers
310 following
7 posts
#IBD #DGBI #AIH Patient Thought Leader
CEO & Co-Founder of @southasianibd @ibdesis
Founder of OwnYourCrohns.com
Posts
Media
Videos
Starter Packs
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
IBD Doctor
@ibddoctor.bsky.social
· Apr 13
Preclinical Protein Signatures of Crohn’s Disease and Ulcerative Colitis: A Nested Case-Control Study Within Large Population-Based Cohorts
This study shows that a combination of proteins measured in blood can be used to predict
a future diagnosis of Crohn’s disease.
www.gastrojournal.org
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Rob Brierley
@robbrierley.bsky.social
· Jan 17
FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh® (mirikizumab-mrkz) for...
www.prnewswire.com
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH
Reposted by Tina Aswani-Omprakash, MPH